Employer Profile: Sanofi-aventis

About Sanofi-aventis

With 2004 pro forma combined net sales (1) of 25,418 million euros, +10.0% and an estimated 100,000 employees worldwide, sanofi-aventis is the world’s 3rd largest pharmaceutical company and ranks among the top 5 in the United-States. Global headquarters are located in Paris, France and U.S. headquarters are in Bridgewater, NJ.

7 major therapeutics areas

Sanofi-aventis focuses its activities on 7 major therapeutic areas: Cardiology, Thrombosis, Oncology, Internal Medicine, Metabolic disorders, diseases of the Central Nervous System and Vaccines.

Great medicines for millions of patients

The sanofi-aventis portfolio of marketed products contains several medicines that are world leaders in their respective classes including: Lovenox® (enoxaparin sodium), Plavix® (clopidogrel bisulfate), Allegra® (fexofenadine), Ambien® (zolpidem tartrate), Avapro® (irbesartan), Eloxatin™ (oxaliplatin), Ketek® (telithromycin), Lantus® (insulin glargine), Actonel® (risedronate sodium)and Taxotere® (docetaxel).

Six of these of products are confirmed global blockbusters while another two popular products are nearing similar status.

In the U.S.market, sanofi-aventis continues to outperform its competition in the market while posting the highest growth percentage for the 4th consecutive year.

A highly productive and innovation R&D organization

The foundation of sanofi-aventis's worldwide growth is an industry-leading R&D organization that is comprised of approximately 11,000 scientists working in over 20 research centers around the world. Sanofi-aventis maintains its commitment to creating innovative therapeutic treatments and has devoted over 4 billion euros to its current portfolio that includes over 40 compounds presently in advanced stages of development.

For more information about sanofi-aventis worldwide, visit www.sanofi-aventis.com.

All contents © Copyright 2005 Sales Careers Online All rights reserved.